Vet Med - Czech, 2026, 71(10):415-421 | DOI: 10.17221/34/2026-VETMED
Impact of preanalytical sample handling on GLP-1 measurement in porcine plasma: A pilot ELISA-based studyOriginal Paper
- 1 Clinic for Swine, University Veterinary Hospital, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovak Republic
- 2 Department of Public Veterinary Medicine and Animal Welfare, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovak Republic
- 3 Department of Morphological Disciplines, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovak Republic
- 4 Clinic for Ruminants, University Veterinary Hospital, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovak Republic
- 5 Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovak Republic
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that plays a key role in the regulation of glucose metabolism; however, it is highly sensitive to biological sample handling conditions. The aim of this pilot study, conducted in two piglets and two adult finishing pigs, was to compare the effects of selected preanalytical factors on measured GLP-1 concentrations in porcine plasma and to identify conditions suitable for its reliable determination using ELISA. The evaluated factors included blood collection tube type (EDTA vs EDTA with a DPP-4 inhibitor), centrifugation temperature (4 °C vs room temperature), and sample processing conditions (fresh vs frozen samples). In addition, the influence of the physiological status of the animals (fasting vs post-glucose administration) was assessed. Samples collected in tubes containing a DPP-4 inhibitor showed higher measured GLP-1 concentrations than standard EDTA samples. Samples processed at room temperature showed higher GLP-1 concentrations compared to samples centrifuged at 4 °C. The obtained results suggest that sample handling conditions may significantly influence GLP-1 determination by ELISA. The use of EDTA tubes containing a DPP-4 inhibitor combined with rapid sample processing and centrifugation at 4 °C may represent a suitable procedure for standardised GLP-1 measurement.
Keywords: DPP-4 inhibitor; ELISA; GLP-1; porcine plasma; sample handling; sample stability
Received: May 13, 2026; Revised: July 30, 2026; Accepted: August 3, 2026; Prepublished online: October 9, 2026; Published: October 15, 2026 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Albrechtsen NJW, Kuhre RE, Deacon CF, Holst JJ. Targeting the intestinal L-cell for obesity and type 2 diabetes treatment. Expert Rev Endocrinol Metab. 2014 Jan;9(1):61-72.
Go to original source...
Go to PubMed... - Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007 May;132(6):2131-57.
Go to original source...
Go to PubMed... - Chiu ML, Lawi W, Snyder ST, Wong PK, Liao JC, Gau V. Matrix effects: A challenge toward automation of molecular analysis. J Assoc Lab Autom. 2010;15(4):233-42.
Go to original source... - Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes. 1995 Sep;44(9):1126-31.
Go to original source... - Deacon CF. Circulation and degradation of GIP and GLP-1. Horm Metab Res. 2004 Nov-Dec;36(11-12):761-5.
Go to original source...
Go to PubMed... - Drucker DJ. The biology of incretin hormones. Cell Metab. 2006 Mar;3(3):153-65.
Go to original source...
Go to PubMed... - Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab. 2005 Jun;31(3 Pt 1):233-42.
Go to original source... - Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007 Oct;87(4):1409-39.
Go to original source...
Go to PubMed... - Knapper JM, Morgan LM, Fletcher JM, Marks V. Plasma and intestinal concentrations of GIP and GLP-1 (7-36) amide during suckling and after weaning in pigs. Horm Metab Res. 1995 Nov;27(11):485-90.
Go to original source... - Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease. Diabetes Obes Metab. 2018 Feb;20(Suppl_1):5-21.
Go to original source...
Go to PubMed... - Plamboeck A, Holst JJ, Carr RD, Deacon CF. Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig. Diabetologia. 2005 Sep;48(9):1882-90.
Go to original source...
Go to PubMed... - Saracevic A, Dukic L, Simundic AM. Haemolysis and lipemia interfere with resistin and myeloperoxidase BioVendor ELISA assays. Biochem Med (Zagreb). 2019 Jun 15;29(2):020703.
Go to original source... - Soderstrom AC, Nybo M, Nielsen C, Vinholt PJ. The effect of centrifugation speed and time on pre-analytical platelet activation. Clin Chem Lab Med. 2016 Dec 1;54(12):1913-20.
Go to original source... - Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev. 2004 May;25(2):105-20.
- Yi J, Liu Z, Gelfand CA, Craft D. Investigation of peptide biomarker stability in plasma samples using time-course MS analysis. Methods Mol Biol. 2011;728:161-75.
Go to original source...
Go to PubMed... - Yi J, Warunek D, Craft D. Degradation and stabilization of peptide hormones in human blood specimens. PLoS One. 2015 Jul 29;10(7):e0134427.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Attribution 4.0 International (CC BY 4.0.), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.

ORCID...